Banded Versus Non-Banded Sleeve in Class IV Obese Patients
Randomized Controlled Trial (RCT) of Banded Versus Non-Banded Sleeve Gastrectomy in Class IV Obese Patients: 3-Year Follow-up
1 other identifier
interventional
219
1 country
1
Brief Summary
Obesity remains a major global health challenge, with Class IV super obesity (BMI ≥ 50 kg/m²) being the most severe form. This condition is associated with numerous comorbidities including type 2 diabetes, hypertension, obstructive sleep apnea, and hyperlipidemia, which significantly reduce life expectancy and quality of life. Bariatric surgery, particularly sleeve gastrectomy (SG), has been shown to be an effective treatment for morbid obesity. While SG results in significant weight loss and improvement of comorbidities, some patients experience weight regain over time. Banded sleeve gastrectomy (BSG) has been proposed as a modification of SG to enhance long-term outcomes by providing additional restriction via a polypropylene band around the proximal gastric pouch. Although initial evidence for banded procedures suggests improved outcomes, particularly in the context of weight loss and reduced weight regain, specific evidence for Class IV obesity remains limited.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2025
CompletedFirst Submitted
Initial submission to the registry
July 17, 2025
CompletedFirst Posted
Study publicly available on registry
August 3, 2025
CompletedAugust 3, 2025
July 1, 2025
3 years
July 17, 2025
July 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Weight Loss (TWL)
Total Weight Loss between the 2 groups (in kilograms)
Measured at 6, 12, 24 and 36 months postoperatively
Secondary Outcomes (9)
Resolution of associated medical problems
6, 12, 24, and 36 months.
Resolution of associated medical problems
6, 12, 24, and 36 months.
Resolution of associated medical problems
6, 12, 24, and 36 months.
Resolution of associated medical problems
6, 12, 24, and 36 months.
Complications
post operative, 12, 24, and 36 months
- +4 more secondary outcomes
Study Arms (2)
Banded Group
ACTIVE COMPARATORPlacement of a 1.5 x 5.5 cm polypropylene band
Non-Banded Group
PLACEBO COMPARATORStandard laparoscopic sleeve gastrectomy
Interventions
Laparoscopic sleeve gastrectomy with the placement of a 1.5 x 5.5 cm polypropylene band around the proximal gastric pouch to enhance restriction.
Standard laparoscopic sleeve gastrectomy where approximately 75-80% of the stomach is resected to form a tubular structure
Eligibility Criteria
You may qualify if:
- Adults aged 18-60 years
- BMI ≥ 50 kg/m² (Class IV obesity)
- No prior gastrointestinal surgeries
- No significant psychiatric or medical contraindications to surgery
- Ability to provide informed consent
You may not qualify if:
- BMI \< 50 kg/m²
- Refusal to undergo band placement
- Active reflux disease or PPI use
- Prior bariatric surgery
- Pregnancy plans during the study period
- Active cancer or life-limiting illness
- Substance abuse or non-compliance with postoperative care
- Gastroesophageal reflux disease.
- Hiatal hernia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The surgical department of Medical Research Institute Hospital, Alexandria University
Alexandria, 21531, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed Ashour, Ph.D. (Professor)
The surgical department of Medical Research Institute Hospital, Alexandria University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of General surgery
Study Record Dates
First Submitted
July 17, 2025
First Posted
August 3, 2025
Study Start
June 15, 2022
Primary Completion
June 15, 2025
Study Completion
July 15, 2025
Last Updated
August 3, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- whole study period
- Access Criteria
- Ask contact person
The analysis will be performed on a blinded dataset after completing the medical/scientific review. All protocol violations will be identified and resolved, and the dataset will be declared complete. All data will be collected in a data management system (Castor EDC, Amsterdam, The Netherlands; https://www.castoredc.com), handled according to Good Clinical Practice guidelines, Data Protection Directive certificate, and complied with Title 21 CFR Part 11. Furthermore, the data centers where all the research data will be stored are certified according to ISO27001, ISO9001, and Dutch NEN7510. Can be asked by the contact person